The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > CHUK protein, human

CHUK protein, human

The CHUK protein, also known as IKK-alpha, is a serine/threonine protein kinase that plays a crucial role in the regulation of the NF-kappa-B transcription factor.
It is a key component of the IkappaB kinase (IKK) complex, which is responsible for the phosphorylation and subsequent degradation of the NF-kappa-B inhibitor IkappaB.
This process allows the nuclear translocation and activation of NF-kappa-B, which regulates the expression of genes involved in immune and inflammatory responses, cell survival, and other cellular processes.
The CHUK protein is widely expressed and has been implicated in a variety of human diseases, including inflammation, cancer, and autoimmune disorders.
Understanding the structure, function, and regulation of the CHUK protein is an active area of research and is of significant therapeutic interest.

Most cited protocols related to «CHUK protein, human»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
CHUK protein, human Gene Expression Genus Loris Homo sapiens Institutional Animal Care and Use Committees Klebsiella pneumoniae Lung Lung Neoplasms Microarray Analysis Mus Operative Surgical Procedures Paraffin Patients sodium copper chlorophyllin Squamous Cell Carcinoma STK11 protein, human Tissues
PWMs for 16 transcription factors have previously been collated [17 (link)] from various in vitro SELEX and DNaseI footprinting experiments that used purified transcription factor protein and naked DNA [70 (link)] (BDTNP, unpublished data). For convenience these are provided in Additional file 13. These PWMs were used to identify all DNA sequences that match them genome-wide at P-values <0.04 using Fimo [107 (link)]. For each factor, these recognition site occurrences were then divided into two groups depending on whether the matches were located within 5% FDR DNaseI accessible regions or whether they were in inaccessible chromatin. The recognition sites were then further broken down into cohorts in R based on P-values as follows:
For each cohort, the maximum ChIP-chip signal from the relevant factor within 250 bp of each sequence match was determined using input DNA normalized ChIP-chip scores calculated as Array hybridization signal for factor immunoprecipitation/Array hybridization signal for input crosslinked DNA (see Figure 2 in [14 (link)]) except that natural numbers, not log2, were used here. The 95% confidence interval about the median of these scores was calculated using R's box plot function (Figure 4; Additional file 8).
In addition, ten permutations of each original PWM were generated by shuffling the order of positions in the weight matrices for each permutation. If any permutation that matched any other of the randomly generated permutations for that factor or the normal PWM of one of the other 15 factors (P < 0.05 defined using Tomtom [108 (link)]) it was discarded and a new permutation was generated. The set of sequence matches to these scrambled PWMs were then identified throughout the genome, separated into those in open or closed chromatin and binned into groups based on affinity in the same manner as for the genuine motifs. The maximum ChIP-chip scores within 250 bp of each scrambled recognition site occurrence was determined and the median of this peak score was determined over the entire set of ten scrambled PWMs for each factor and the 95% confidence limits calculated as for the matches to the genuine PWMs (Figure 4; Additional file 8).
To correlate accessibility with ChIP-chip scores (Figure 5a), peaks in accessibility at stage 5 were annotated with maximum input DNA normalized ChIP-chip scores within 75 bp of each peak for the 16 factors with well-characterized in vitro binding specificities (Figure 4; Additional file 8). The peaks were ranked by accessibility and the correlation between level of accessibility and ChIP-chip score was calculated using R's Pearson correlation function. The DNaseI peaks were then ranked, separated into cohorts of 200 similarly accessible peaks and the median peak in ChIP-chip signal for each cohort was determined and plotted using R's heat map function scaling rows to account for inherent differences in ChIP-chip signal between factors. A similar process was used to correlate accessibility with the presence of recognition sites for each of the 16 factors (Figure 5b). The same PWMs for the factors derived from in vitro DNA binding data, described above, were employed to identify all sequence matches to these matrices within 75 bp of peaks of accessibility with P < 0.003 using Fimo [107 (link)] (that is, matches that fell into at least the -3 cohort from Figure 4). The correlation between the level of accessibility and the number of PWM matches was calculated using R's Pearson correlation function. For each factor, the peaks in accessibility were ranked and divided into cohorts of 200 and the sum of all recognition sites was added over each cohort and plotted in R using the heat map function, while scaling rows to one another in order to account for differences in information content between PWMs.
Full text: Click here
Publication 2011
6H,8H-3,4-dihydropyrimido(4,5-c)(1,2)oxazin-7-one Acid Hybridizations, Nucleic ChIP-Chip Chromatin CHUK protein, human DNA Chips DNA Sequence Genome Immunoprecipitation Pokeweed Mitogens Proteins Transcription Factor

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
Biological Assay Cells CHUK protein, human Immunoprecipitation Molecular Sieve Chromatography Phosphotransferases Proteins Retroviridae Roentgen Rays

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
Biological Assay Cells CHUK protein, human Immunoprecipitation Molecular Sieve Chromatography Phosphotransferases Proteins Retroviridae Roentgen Rays
GM-CSF and IL-4 were from Peprotech. 0.1 μM CpG (Invivogen), 500 ng/ml Pam3CSK4 (Invivogen), 100 ng/ml LPS (Sigma, B5:055) and 0.5 μg/ml LTβR agonist (Biogen, Inc.) were used to stimulate cells. Cycloheximide and IKK2 inhibitor (PS-1145) were from Sigma. Antibodies to RelA (sc-372), RelB (sc-226), c-Rel (sc-70), IκBα (sc-371), IκBβ (sc-945), IκBε (sc-7155), IKK1 (sc-7606), TRAF3 (sc-6933), USF-2 (sc-861), α-tubulin (sc-5286), β-actin (sc-1615) and CD16/CD32 (sc-18867) were from Santa Cruz Biotechnology. p105/p50, p100/p52 and antibody to p100 C-terminus were from National Cancer Institute, Biological Resources Branch, Frederick, MD. NIK antibody (4994) was from Cell Signaling. Immunoprecipitation beads and HRP-conjugated anti-rabbit secondary antibody were from eBioscience.
Publication 2012
Actins alpha, NF-KappaB Inhibitor alpha-Tubulin Antibodies Antibodies, Anti-Idiotypic Biopharmaceuticals Cells CHUK protein, human Cycloheximide Granulocyte-Macrophage Colony-Stimulating Factor Immunoglobulins Immunoprecipitation PS1145 Rabbits RELA protein, human rel Oncogene SC 372 TNF Receptor-Associated Factor 3 TPX2 protein, human

Most recents protocols related to «CHUK protein, human»

Our study site was the University Teaching Hospital of Kigali (CHUK, a French
acronym), the largest teaching and tertiary level hospital in Rwanda, with a
519-bed capacity, located in Nyarugenge District, City of Kigali, the capital of
the Republic of Rwanda.21 The pathology department at this hospital has five
anatomic pathologists and processes around 3500 biopsies and 1000 cytology
specimens per year. Contrary to some developed countries with a considerable
number of pathologists, the practice of pathology is not based on subspecialty.
Therefore, the pathologists will be required to examine any type of issue
brought to their attention.
Publication 2023
Attention Biopsy CHUK protein, human Pathologists
The AIA rats were sacrificed on day 23 post-adjuvant induction. The CIA mice were sacrificed on day 33 post-primary immunization. The animals were dissected to obtain synovitis of joint tissues. The total RNA of tissues was extracted in TRNzol Universal reagent by vigorous mechanical shaking. The cDNA synthesis was performed using PrimeScript RT reagent kit and subjected to qPCR reaction using TB Green Premix Ex Taq (Tli RNaseH Plus) kit on ABI 7500 systems (Applied Biosystems, Foster City, CA). The relative mRNA expression was normalized by 2-ΔΔCt method, and the primer sequences for Tnf, Il1b, Il6, Tab2, Tab3, Ikka, and Actb are listed in Supplementary Table 1.
Full text: Click here
Publication 2023
Anabolism Animals CHUK protein, human DNA, Complementary IL1B protein, human Joints Mus Oligonucleotide Primers Pharmaceutical Adjuvants Rattus norvegicus RNA, Messenger Synovitis Tissues Vaccination
The cell culture and miR-23b transfection were conducted as described in the section Cell apoptosis analysis. The total RNA of treated cells was extracted by TRNzol Universal reagent, and 2 μg RNA was utilized for the cDNA synthesis using PrimeScript RT reagent kit. Subsequently, 1 μg cDNA was applied for qPCR reaction by TB Green Premix Ex Taq (Tli RNaseH Plus) kit on ABI 7500 systems (Applied Biosystems, Foster City, CA). The relative expression levels of Tnf, Il1b, Il6, Tab2, Tab3, and Ikka were measured by 2-ΔΔCt method using Actb as the reference gene. The sequences of primers used are listed in Supplementary Table 1.
Full text: Click here
Publication 2023
Anabolism Apoptosis Cell Culture Techniques CHUK protein, human DNA, Complementary Genes Interleukin-1 Oligonucleotide Primers Transfection
In the western blotting assay, antibodies for TAB2 (3745, clone C88H10, lot 1, dilution 1:1000) and IKKA (2682S, lot 5, dilution 1:1000) were purchased from Cell Signaling Technology (Beverly, MA). Anti-TAB3 (ab124723, clone EPR5965, lot GR83293-9, dilution 1:5000), anti-ACTB (ab227387, lot GR3263411-3, dilution 1:5000) and horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary antibody (ab6721, lot GR172025-4, GR297013-3, dilution 1:5000) were obtained from Abcam (Shanghai, China). In immunochemical analysis of joints, antibodies for TAB2 (NBP2-68833, lot R92304, dilution 1:1000) and cadherin 11 (NBP2-15661, lot 44034, dilution 1:250) were purchased from Novus Biologicals (Littleton, CO). Antibodies for TAB3 (PA5-116885, lot 3364EA11 and 35E8BA35, dilution 1:1000) were purchased from Invitrogen (Carlsbad, CA). Antibodies for IKKA (ab32041, clone Y463, lot GR117080-29 and GR3368230-15, dilution 1:1000), F4/80 (ab16911, clone BM8, lot GR3297595-4, dilution 1:50), Ki67 (ab16667, clone SP6, lot GR3375640-34, dilution 1:200) and horseradish peroxidase (HRP)-conjugated secondary antibody were acquired in Abcam (Shanghai, China). Anti-osteocalcin (23418-1-AP, lot GR3313195-53, dilution 1:100) was obtained from Proteintech (Chicago, IL). Peroxidase AffiniPure Goat Anti-Rabbit IgG (H + L) (111-035-045, lot 00000130634, dilution 1:500) and Alexa Fluor 488 goat anti-rabbit IgG secondary antibody (111-545-003, lot 000000101724, dilution 1:500) were acquired from Jackson ImmunoResearch (West Grove, PA). All commercially available antibodies have been validated by their manufacturer as indicated in their respective datasheet and/or website.
Full text: Click here
Publication 2023
alexa fluor 488 anti-IgG Antibodies Biological Factors CHUK protein, human Clone Cells Goat Horseradish Peroxidase Immunoglobulins Joints Novus osteoblast cadherin Osteocalcin Peroxidase PLAGL1 protein, human Rabbits Technique, Dilution Western Blot
Lysis buffer (1% Triton X-100 (Sigma-Aldrich), 100 mM Tris-HCl (pH 7.5), 10 mM NaCl, 10% glycerol (Amresco, Solon OH, USA), 50 mM sodium fluoride (Sigma-Aldrich), 1 mM phenylmethylsulfonyl fluoride (PMSF; Sigma-Aldrich), 1 mM p-nitrophenyl phosphate (Sigma-Aldrich), and 1 mM sodium orthovanadate (Sigma-Aldrich)) was used to lyse the cells, and the cell lysates were centrifuged at 13,000 rpm for 15 min at 4 °C. Bradford protein assay reagent (Bio-Rad) was used to quantify the amount of protein in the supernatant, and 10% or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis resolved these proteins. The separated proteins were then placed on a nitrocellulose paper membrane (Bio-Rad), where they were blocked with 5% skimmed milk in Tris-buffered saline for 1 h. Following that, the appropriate primary antibodies were used to incubate the membranes against GPR50 (14032S, 1:1000), NANOG (SC33759, 1:300), OCT3/4 (SC-5279, 1:300), SOX-2 (SC-20088, 1:300), IKKa (19930S, 1:1000), IKBa (4814S, 1:1000), p-IKBa (2859S, 1:1000), p65 (D14E12, 1:1000), p-p65 (3033S, 1:1000), BAX (CST2772S, 1:1000), NOTCH1 (SC373891, 1:1000), T-AKT (92112, 1:800), p-AKT (SC-29315, 1:300), BCL-2 (SC-492, 1:300), TACE (SC-6416, 1:300), a-tubulin (SC-23975, 1:300), HES1 (SC-13844, 1:500), b-actin (SC-47778, 1:1000) (Santa Cruz Biotechnology, Dallas, TX, USA), and intracellular domain (ab83232, 1:1000) (Abcam, Cambridge, UK) overnight at 4 °C. A 2 h incubation was followed by rabbit (SC-2004), anti-mouse (SC-2005), -goat (SC-2020), or -rat (SC-2006) IgGs (1:1000) that were tagged with horseradish peroxidase (Santa Cruz Biotechnology). A high-performance chemiluminescence kit (Amersham Bioscience, Piscataway, NJ, USA) was used to track protein signals.
Full text: Click here
Publication 2023
Actins ADAM17 protein, human Antibodies BCL2 protein, human Biological Assay Buffers Cells Chemiluminescence CHUK protein, human Glycerin Goat Horseradish Peroxidase Milk, Cow's Mus Nitrocellulose nitrophenylphosphate Orthovanadate Phenylmethylsulfonyl Fluoride POU5F1 protein, human Proteins Protoplasm Rabbits Saline Solution SDS-PAGE Sodium Sodium Chloride Sodium Fluoride Solon SOX2 protein, human Tissue, Membrane Triton X-100 Tubulin

Top products related to «CHUK protein, human»

Sourced in United States, United Kingdom, China, Germany, Canada, Morocco, Japan, Italy, Switzerland, France, Israel, Singapore, Hong Kong, Sweden, Macao, Panama
β-actin is a cytoskeletal protein that is ubiquitously expressed in eukaryotic cells. It is a component of the microfilament system and plays a crucial role in various cellular processes, such as cell motility, maintenance of cell shape, and intracellular trafficking.
Sourced in United States
Anti-IKK1/2 is a primary antibody product designed to detect IKK1 (IkappaB kinase 1) and IKK2 (IkappaB kinase 2) proteins. IKK1 and IKK2 are serine/threonine protein kinases that play a crucial role in the activation of the NF-kappaB signaling pathway. This antibody can be used in various research applications, such as Western blotting, immunoprecipitation, and immunohistochemistry, to study the expression and regulation of IKK1 and IKK2 proteins.
Sourced in United States, Germany, China, United Kingdom, Canada, Macao, Italy, Japan, France
BAY11-7082 is a laboratory compound that inhibits the activation of the NF-κB transcription factor. It is commonly used in research settings to study the role of NF-κB signaling in various biological processes.
Sourced in United States, United Kingdom, China, Germany
Phospho-IκBα is a laboratory reagent used to detect the phosphorylated form of the IκBα protein. IκBα is an inhibitor of the NF-κB transcription factor, and its phosphorylation leads to the activation of NF-κB signaling. This product can be used in techniques such as Western blotting and immunohistochemistry to analyze the activation state of the NF-κB pathway.
Sourced in United States, United Kingdom, China, Japan, Canada
Anti-IκBα is a primary antibody that specifically binds to the IκBα protein. IκBα is an inhibitor of the NF-κB transcription factor, which plays a central role in regulating immune and inflammatory responses. This antibody can be used to detect and study the expression and regulation of IκBα in various biological systems.
Sourced in United States, United Kingdom, China, Japan
NF-κB p65 is a protein subunit of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) transcription factor complex. It plays a central role in regulating the immune response and inflammation.
Sourced in United States
Anti-rabbit-Ig is a laboratory reagent used for the detection and quantification of rabbit immunoglobulins in various experimental applications. Its core function is to specifically bind to rabbit immunoglobulins, allowing for their identification and measurement.
Sourced in United States, China, United Kingdom
P-IκBα is an antibody that recognizes the phosphorylated form of the IκBα protein, a key regulator of the NF-κB signaling pathway. This antibody can be used to detect the activation of the NF-κB pathway in cells.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, China, United Kingdom, Germany, Japan, France, Canada, Switzerland, Denmark, Belgium, Italy, Australia, Singapore, Spain, Colombia, Sweden, Netherlands, New Zealand, Poland, Pakistan, Lithuania
Lipofectamine RNAiMAX is a transfection reagent designed for efficient delivery of small interfering RNA (siRNA) and short hairpin RNA (shRNA) into a wide range of cell types. It is a cationic lipid-based formulation that facilitates the uptake of these nucleic acids into the target cells.

More about "CHUK protein, human"

The CHUK protein, also known as IKK-alpha, is a crucial regulator of the NF-kappa-B transcription factor, which plays a vital role in immune and inflammatory responses, cell survival, and other cellular processes.
As a serine/threonine protein kinase, CHUK is a key component of the IkappaB kinase (IKK) complex, responsible for the phosphorylation and subsequent degradation of the NF-kappa-B inhibitor IkappaB.
This process allows the nuclear translocation and activation of NF-kappa-B, a transcription factor that regulates the expression of various genes.
CHUK is widely expressed and has been implicated in a variety of human diseases, including inflammation, cancer, and autoimmune disorders.
Understanding the structure, function, and regulation of the CHUK protein is an active area of research and is of significant therapeutic interest.
In the context of experimental research, the CHUK protein can be studied using various techniques and reagents, such as β-actin (a commonly used internal control), Anti-IKK1/2 (an antibody that recognizes IKK-alpha and IKK-beta), BAY11-7082 (an inhibitor of IkappaB kinase), Phospho-IκBα (an antibody that detects the phosphorylated form of the NF-kappa-B inhibitor IκBα), Anti-IκBα (an antibody that recognizes the NF-kappa-B inhibitor IκBα), NF-κB p65 (a subunit of the NF-kappa-B transcription factor), Anti-rabbit-Ig (a secondary antibody used for detection), P-IκBα (the phosphorylated form of IκBα), FBS (fetal bovine serum, a common cell culture supplement), and Lipofectamine RNAiMAX (a transfection reagent used for delivering siRNA or other nucleic acids into cells).
PubCompare.ai's AI-powered research optimization tool can help researchers unlock reproducibility for CHUK protein analysis by locating protocols from literature, pre-prints, and patents, and using AI-driven comparisons to identify the best protocols and products for their research needs.
This can streamline the experimental process and improve the reliability of CHUK protein-related research.